Cellular Dynamics' Q2 Revenues Rise 29 Percent | GenomeWeb

NEW YORK (GenomeWeb) – Cellular Dynamics International today reported that its second quarter revenues increased 29 percent year over year, but the firm missed Wall Street estimates on the top and bottom lines.

The Madison, Wis.-based provider of stem cells for research purposes reported total revenues of $3.6 million for the three months ended June 30, up from $2.8 million in the second quarter of 2013. Analysts, on average, had expected revenues of $4.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: SNP reference panel from the Haplotype Reference Consortium, and more.

Halloran Consulting's Laurie Halloran lists at Stat News the mistakes she sees startup companies make when pursuing a clinical trial.

MIT researchers are using bees to collect and visualize urban microbiome samples, Wired reports.

Reliance on Excel leads to errors in gene name lists, a new Genome Biology paper reports.